Literature DB >> 48723

Phagocytosis in patients and carriers of chronic granulomatous disease.

W D Biggar.   

Abstract

The phagocytic capacity of leucocytes from four patients and two carriers of chronic granulomatous disease (C.G.D.) was compared to that of normal leucocytes. Leucocytes from C.G.D. patients phagocytised more Staphylococcus aureus than did normal leucocytes after 5, 10, and 20 minutes of incubation. Phagocytosis by leucocytes from two carriers of C.G.D. was intermediate between that in the patients and in controls. In contrast, phagocytosis of Streptococcus faecalis, an organism readily killed by C.G.D. leucocytes, was similar for control and C.G.D. leucocytes. Enhanced phagocytosis may represent an attempt by leucocytes to compensate for a bactericidal abnormality. In addition, these observations may partly explain why carriers of C.G.D. are not more susceptible to infection despite abnormal leucocyte function. Detection of carriers using the described assay of phagocytosis appears relatively simple compared to previously described methods.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 48723     DOI: 10.1016/s0140-6736(75)91943-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  4 in total

1.  Phagocytosis and intracellular killing of coagulase-negative staphylococci.

Authors:  F Namavar; J de Graaff; D M MacLaren
Journal:  Med Microbiol Immunol       Date:  1979-03-13       Impact factor: 3.402

2.  Studies of phagocytosis in chronic granulomatous disease.

Authors:  T A Gaither; S R Medley; J I Gallin; M M Frank
Journal:  Inflammation       Date:  1987-06       Impact factor: 4.092

3.  Use of lysostaphin to remove cell-adherent staphylococci during in vitro assays of phagocyte function.

Authors:  C S Easmon; H Lanyon; P J Cole
Journal:  Br J Exp Pathol       Date:  1978-08

4.  Chronic granulomatous disease in an adult.

Authors:  D A Burns; I Sarkany
Journal:  J R Soc Med       Date:  1979-02       Impact factor: 18.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.